Alluviam Awarded New Patent for HazMasterG3 Technology

Alluviam has earned an additional patent for our proprietary decision support technology.  This technology is currently embedded in HazMasterG3, the leading mobile CBRNE/HME decision support system available today.  The patent expands upon our existing family of proprietary technologies, and reinforces HazMasterG3's market defining role in CBRNE/HME decision support systems.  This patent is yet another example of how private sector innovation moves the state of the art forward, benefitting both the military and civilian community. The newly patented technology advances HazMasterG3's unique abilities to identify precursors and their intended formulations, along with proprietary mixture formulation technology that uniquely enables HazMasterG3 to determine which finished products could be synthesized from a set of suspected precursors.  

These advances serve as a stark reminder to IWTSD and other government agencies that have siphoned scarce R&D funds away from true innovation, robbing those on the front lines of truly innovative technologies by instead duplicating existing commercially available solutions soley to fund their own pet projects, as better explained here.